In skin fibroblasts from MKD patients, decreased membrane-bound and increased soluble levels of activated RhoA and Rac1 were observed at lower concentrations of simvastatin, an inhibitor of HMGR, than in control fibroblasts (20, 56). This evidence concerns the gene RHOA and mevalonic aciduria.